CVS

CVS Health Corporation ·NYSE·Healthcare
94.73 live · 2026-08-12 15:59

Some scores are at the bottom of their range

This score sits at the bottom of the 0–100 range. The underlying calculation was negative, so the displayed value is a floor, not a measurement of zero.

  • Tactical Score: displayed 0, underlying value -121.1
1.7%
Brown Bear Score
10.1%
Business Conviction Score
20.1%
Position Health Score
1.5%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +44.6% · range 65.51–110.60

The Businesswhat the company reports

Business & cash flow

FCF / assets 3.1%
OCF / assets 4.2%
FCF / revenue 2.6%
Gross margin 13.6%
ROIC 3.2%
Forward P/E 11.1

FCF/assets and OCF/assets are the cash-flow measures Brown Bear's own testing found to survive; FCF/revenue is shown alongside for context. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Forward EPS growth has outpaced trailing price return by +76.8pp

Confidence 95.0/100

Takeaway Earnings growth is outpacing price — consistent with the stock not yet fully reflecting its improving forward estimates.

Reported earnings

Next report 2026-10-27 before the open · consensus EPS 1.66

Q2 23 revenue: 88.92bnQ2 23 net income: 1.90bnQ2 23 EPS: 1.48Q3 23 revenue: 89.76bnQ3 23 net income: 2.26bnQ3 23 EPS: 1.75Q3 23Q4 23 revenue: 93.81bnQ4 23 net income: 2.05bnQ4 23 EPS: 1.59Q1 24 revenue: 88.44bnQ1 24 net income: 1.11bnQ1 24 EPS: 0.88Q1 24Q2 24 revenue: 91.23bnQ2 24 net income: 1.77bnQ2 24 EPS: 1.41Q3 24 revenue: 95.43bnQ3 24 net income: 87.00mQ3 24 EPS: 0.07Q3 24Q4 24 revenue: 97.71bnQ4 24 net income: 1.64bnQ4 24 EPS: 1.30Q1 25 revenue: 94.59bnQ1 25 net income: 1.78bnQ1 25 EPS: 1.41Q1 25Q2 25 revenue: 98.92bnQ2 25 net income: 1.02bnQ2 25 EPS: 0.80Q3 25 revenue: 102.87bnQ3 25 net income: -3.98bnQ3 25 EPS: -3.13Q3 25Q4 25 revenue: 105.69bnQ4 25 net income: 2.94bnQ4 25 EPS: 2.32Q1 26 revenue: 100.43bnQ1 26 net income: 2.94bnQ1 26 EPS: 2.30Q1 26

Revenue Net incomeEPS (GAAP) (-3.13–2.32, own scale) Derived Q4

12 quarters to Q1 26. Revenue and net income share one scale, so the gap between them is the margin. The baseline is zero — bars below it are losses. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-03-31 100.43bn +6.2% 2.94bn 2.30 2.57 +15.8% 2026-05-06
2025-12-31 (derived) 105.69bn +8.2% 2.94bn 2.32 1.09 +8.8% 2026-02-10
2025-09-30 102.87bn +7.8% -3.98bn -3.13 1.60 +15.7% 2025-10-29
2025-06-30 98.92bn +8.4% 1.02bn 0.80 2025-07-31

Earnings response

Typical move around a filing ±3.1%
On an ordinary two days ±1.4% — filings move it 2.3× as much
Direction 7 up, 4 down over 11 filings
Revenue change and price reaction, by quarter
Q3 22 revenue +10.0% year on yearQ3 22 filed 2022-11-02: price +3.4%Q1 23 revenue +11.0% year on yearQ1 23 filed 2023-05-03: price -5.5%Q1 23Q2 23 revenue +10.3% year on yearQ2 23 filed 2023-08-02: price +0.5%Q3 23 revenue +10.6% year on yearQ3 23 filed 2023-11-01: price +0.9%Q3 23Q1 24 revenue +3.7% year on yearQ1 24 filed 2024-05-01: price -18.5%Q2 24 revenue +2.6% year on yearQ2 24 filed 2024-08-07: price -0.8%Q2 24Q3 24 revenue +6.3% year on yearQ3 24 filed 2024-11-06: price +3.1%Q1 25 revenue +7.0% year on yearQ1 25 filed 2025-05-01: price +1.1%Q1 25Q2 25 revenue +8.4% year on yearQ2 25 filed 2025-07-31: price +0.3%Q3 25 revenue +7.8% year on yearQ3 25 filed 2025-10-29: price -6.7%Q3 25Q1 26 revenue +6.2% year on yearQ1 26 filed 2026-05-06: price +8.3%

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-03-31 2026-05-06 +6.2% +8.3% +9.0%
2025-09-30 2025-10-29 +7.8% -6.7% +4.3%
2025-06-30 2025-07-31 +8.4% +0.3% +13.3%
2025-03-31 2025-05-01 +7.0% +1.1% -10.3%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Growing — shares issued
Diluted shares 1,279.0M as at 2026-03-31
Change over 1 year +1.2%
Change over 3 years -0.9%
Public float $86.38bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyFair Value Anchor
Reference band 88.44 — 95.19
Protective stop 84.96 (Atr, 7.5% risk)
Support 75.30 (4 touches, 25.8% away)
Resistance 102.94 (8.7% away)

Takeaway The shares are nearer the ceiling than the floor: about 8.7% below 102.94, where sellers have turned up before, and 25.8% above 75.30, where buyers have stepped in before. That floor has held 4 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 7.5% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice BELOW the cloud | periods 5/14/27 (52% of classic 9/26/52)
LinesTenkan/Kijun BEAR (fresh down cross, 4d ago) | cloud twist BEAR (fresh down, 3d ago)
Cloud thickness83% percentile (thick — substantial structure)
Chikou spanNot clear of price from 26 periods ago
Weekly cloudPrice INSIDE the weekly cloud (context only, not scored)

Takeaway The stock is trading below its cloud — a shaded band drawn from several of its own moving averages, currently 97.30 to 101.84. Being below it means the medium-term picture is pointing downwards, and that band is the first hurdle it would have to climb back through. Its shorter-term averages agree with that. The band is unusually wide at the moment, so it marks a broad zone rather than a single level.

Trailing returns

21 days -10.8%
63 days -0.5%
126 days +25.1%
252 days +46.0%
Below 252d high14.4%

Trend context

PositionAbove trend
ExtensionNormal
Trend slopeFlat
Direction of travelConverging back to trend

Takeaway The share price is above the level its own longer-run trend suggests is fair, and that fair level is going sideways. The gap between the two has been closing. Neither is stretched far enough to stand out.

Volatility

State Expanded out of a squeeze
Current band width21.2% of price
Recent tightest7.0% (6 sessions ago, narrower than 99.0% of its history)
Expansion since3.01×
Band 92.58 — 114.58

Takeaway Lately this share price has been swinging around inside a range roughly 21% wide, and it recently went unusually quiet — calmer than it has been 99% of the time. It has started moving again since, swinging about 3.0 times as widely as during that quiet spell. A stock that has been quiet tends to make its next move look big by comparison, simply because the recent bar was low.

Historical trends

0255075100Share price 93.50–109.922026-07-102026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Repair Pathway

  1. Nearest Trigger Positive 20-day momentum acceleration repair trigger repair engine identifies this as the nearest technical repair catalyst · Broadly stable
  2. Trigger 2 RSI recovery above 50 secondary repair secondary repair catalyst could add confirmation if the primary trigger develops · Deteriorating rapidly
  3. Trigger 3 Relative momentum leadership holds already satisfied Track 2 pathway: relative momentum leadership is already present; maintaining it supports upgrade pressure · Broadly stable
  4. Trigger 4 Volume confirmation above 1.5x +0.50x volume confirmation would improve confidence in the pathway · Deteriorating
  5. Trigger 5 Relative strength stabilisation state change relative momentum rank supports RS stabilisation · Broadly stable

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Below its signal line
Confirmation Marginal
Event Absorption (3 session(s) ago)
Volume percentile91%
Range percentile28%
Close within the bar66% of range
Event level 94.57 (held)

Takeaway The heaviest trading has been happening on days when the price falls: when large numbers of shares change hands, the price has tended to go down rather than up. That tells you where the weight of trading has been. It does not tell you what happens next, and it is not a signal to sell. There was also a day 3 session(s) ago when a great many shares changed hands and the price barely moved — buyers took everything that was offered without the price falling, and it has held since.

Options Positioning

No binary-event flag

CVS: no binary-event flag. Near IV 26%, far IV 32% (ratio 0.81), implied move 3.2%.

Implied volatility 26% near (9d) · 32% far (100d)
Term structure 0.81× near/far
Historical volatility 30%
Implied vs historical 0.85×
Implied move ±3.2% by 2026-08-21
Implied move vs ATR 0.37×
Skew Flat (1.10×)
Call wall 110.00 (+16.1% away)
Put wall 70.00 (-26.1% away)
Gamma pin 110.00

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 3.2% in either direction by 2026-08-21.

Chain as at 2026-08-12. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Stock Rotation Headwind

Rotation health 18.8/100; Severe Rotation Headwind.

Rotation health 18.8
Rotation strength 72.8
LegQuadrantRS-RatioRS-Mom
Stock vs sector Lagging 75.2 90.9
Stock vs SPY Lagging 76.1 94.6
Sector vs SPY Improving 86.4 102.1

Direction of travel: South-West / deteriorating rotation

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 6/9 (+8.0)
  • FCF margin quality: 2.6% (+0.8)
  • High earnings quality (accrual ratio -0.035) (+1.0)
  • Accrual ratio improving (-0.02 -> -0.03) (+2.0)
  • Track 2: ADX 35.3 and rising (+15.0)
  • Track 2: relative momentum rank 0.80 (+10.1)
  • Track 2: Bollinger position 0.10 (+0.8)

Negative signals

  • Underperforming sector over 20 days
  • Track 2: weak MACD histogram (-1.65)
  • Track 2: weak MACD line/signal structure (-12.0)
  • Track 2: negative MACD regime (-8.0)
  • Track 2: MACD slope deteriorating (-8.0)
  • Track 2: weak volume for momentum setup (0.92x average)
  • Relative strength versus sector deteriorating
  • Track 2: negative 20-day momentum acceleration (-0.16)
  • Track 2: bearish DI spread (-37.8)
  • Track 2: price below EMA20 by 6.3%
  • Track 2: EMA20 slope deteriorating -3.7%
  • Track 2: MACD histogram deteriorating (-0.56)
  • Track 2: RSI deterioration/overheating 23.2, 5-day change -11.2
  • Track 2: weak VPT confirmation (-0.10)
  • Track 2: price below EMA50 by 5.4%
  • Track 2: EMA50 slope deteriorating -0.6%
  • Below-average Altman Z-score (1.94)
  • Gross margin improving by -0.1 pts (+-1.0)
  • ROIC improving by -2.2 pts (+-2.0)
  • Track 2 structural exemption: structural score 8.8/100 below the 25 quality floor; this is an unowned speculative candidate, so the universal SELL gate was skipped and the Track 2 momentum/RRG grid was allowed to evaluate instead. Structural quality here is weak by design for this kind of candidate -- treat any resulting BUY as higher risk than a Track 1 signal.

Chase risk is not elevated for this name, so extension penalties are omitted from the negative signals above.